Anemia

Clawed frog helps Fanconi anemia research make leaps

A large, clawed frog is helping Oregon Health & Science University researchers gather a princely sum of knowledge on Fanconi anemia, a rare, genetic, cancer-susceptibility syndrome. Scientists in the OHSU School of Medicine's Department of Biochemistry and Molecular Biology are the first to report a new approach using eggs of the African clawed frog, which goes by the Latin name Xenop...

How bad is malaria anemia? It may depend on your genes

Cell and animal studies conducted jointly by scientists at Johns Hopkins, Yale and other institutions have uncovered at least one important contributor to the severe anemia that kills almost half of the 2 million people worldwide who die each year of malaria. The culprit is a protein cells make in response to inflammation called MIF, which appears to suppress red blood cell production in people w...

Anemia at Biology Products

Rabbit Anti-Fanconi anemia D2, phospho (Ser222) (Poly6180) Polyclonal Antibody, Unconjugated from BioLegend

Description:Purified anti-Fanconi anemia D2-Phosphorylated (Ser222)...
Company:BioLegend

Anemia at Biology Technology

Mirus receives $1.26 million SBIR grant to combat anemia

, a gene therapy researcher, announced on Wednesday that it will receive a $1.26 million Phase II Small Business Innovation Research grant from the National Institutes...

Anemia at Medicine News

Fight anemia by fortifying crops with iron!!!!!!!!

In a path breaking idea researchers at the just concluded Indian science congress in New Delhi have called for a collaborative effort with agricultural scientists to combat anemia with iron fortification of crops. Almost 50% of women and 75% children under 3 years of age are anemic in India. While iron supplementation is expensive, fortification of plants with iron and using it in turn to fight a...

Doctors advice early anemia tests

An estimated 12 to 30% of young children are affected by iron deficiency anemia throughout the world. This is one of the common problems in childhood leading on to problems in simple developmental skills such as standing and walking. Eight-month-old infants with low levels of hemoglobin are significantly more likely to have deformities of the motor system, according to a study conducted by Britis...

Anemia may Lead to Physical Decline

A new study shows anemia may double the risk of an older person developing serious physical declines that can erode the ability to live independently. Researchers say seniors who do not have anemia, but whose blood tests are just above the traditional cut-off point for the condition's diagnosis, are 1.5-times more likely to develop physical declines than those who have normal blood hemoglobin lev...

Anemia Treatment for Cancer Patients

Many patients being treated for cancer complain of feeling weak and tired,// and doctors often prescribe an anemia treatment to relieve these symptoms. A new study suggests that may not be a good idea. Since anemia has been associated with worse prognosis after radiotherapy, the doctors assumed the treatment would make patients feel better and improve results of the therapy, as well....

Anemia Treatment for Cancer Patients

Many patients being treated for cancer complain of feeling weak //and tried, and doctors often prescribe an anemia treatment to relieve these symptoms. A new study suggests that may not be a good idea. Since anemia has been associated with worse prognosis after radiotherapy, the doctors assumed the treatment would make patients feel better and improve results of the therapy, as well....

More>>

Anemia at Medicine Products

EPO EIA Human Cytokines 021-SDX021 Erythropoietin Anemia

Description:EPO EIA Human Cytokines 021-SDX021 Erythropoietin Anemia...
Company:ALPCO Diagnostics

Lyphochek Anemia Control

Description:Lyphochek Anemia Control provides low/deficient values for many analytes specific to anemia, as well as very low TSH values for ultrasensitive TSH testing....
Company:Bio-Rad Laboratories

Anemia at Medicine Technology

Affymax Reports Phase 2 Clinical Dose Ranging Results of Once-Per-Month Hematide for the Treatment of Anemia

PALO ALTO, Calif.--(BUSINESS WIRE)--Jun 25, 2007 - Affymax, Inc.(Nasdaq:AFFY) today announced that additional Phase 2 clinicaltrial results for Hematide(TM) were presented at the European RenalAssociation-EDTA Congress being held in Barcelona, Spain by Iain C.Macdougall, M.D., a Hematide investigator from Kings College,London. Dr. Macdougall's poster included data in previously-treateddialy...

Soliris Effective in PNH Patients With History of Aplastic Anemia and Myelodysplastic Syndromes

- Analysis of Phase III Data Presented at ASCO - CHICAGO, June 04, 2007 /PRNewswire-FirstCall/ -- Investigatorsreported today that Soliris(TM) (eculizumab), a new treatment forparoxysmal nocturnal hemoglobinuria (PNH) developed by AlexionPharmaceuticals, Inc. , is effective in patients diagnosed with PNHwho have a history of aplastic anemia (AA) or myelodysplasticsyndromes (MDS). Soliris...

Researchers Urge Caution in Using ESAs for Cancer-Related Anemia

Drugs Might Increase Risk of Tumor Growth, Data Suggest DURHAM, N.C., April 30, 2007 /PRNewswire/ -- Echoing recent FDAwarnings, a research group from Northern Ireland cautions againstover-aggressive use of a group of drugs called"erythropoiesis-stimulating agents" (ESAs) to treat anemia in somecancer patients, according to a commentary in the April issue ofThe Oncologist, published by Al...

Prospective Model Outlined Potential Time and Cost Savings of Once-Monthly Anemia Treatment

DALLAS, Texas and NUTLEY, N.J., April 23, 2007 /PRNewswire/ --An activity-based cost analysis demonstrated that if a renal anemiatreatment administered once every four weeks replaced thrice weeklyadministration of epoetin alfa, hemodialysis centers may save anestimated 802 nursing hours and more than $44,000 per year per 100patients. These data, from a multi-center prospective analysis of...

Affymax Announces Phase 2 Clinical Trial Results of Once-Per-Month Hematide for the Treatment of Anemia in Patients with Early- and End-Stage Chronic Kidney Disease

PALO ALTO, Calif.--(BUSINESS WIRE)--Apr 23, 2007 - Affymax, Inc.(Nasdaq:AFFY) today announced results to date from two separatePhase 2 clinical trials of Hematide(TM) in dialysis andnon-dialysis chronic kidney disease (CKD) patients. The data showedthat in treatment naive, non-dialysis patients Hematide couldcorrect anemia when administered monthly at an appropriate dose.Similarly, the data...

More>>

Anemia at Medicine Dictionary

Sickle cell anemia

b...

Pernicious anemia

<a href="/ ?q=/ Medicine-Dictionary/ anemia" class=...

Megaloblastic anemia

cells that are larger than normal, usually resulting from a <a href="/ ?q=/ Medicine-Dictionary/ ...

Iron deficiency anemia

...

Immune hemolytic anemia

<A href="http:/ / www.healthc...

More>>